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Foxp3 regulatory T (Treg) cells play a key role in suppression of immune responses during parasitic helminth infection, both by con-
trolling damaging immunopathology and by inhibiting protective immunity. During the patent phase of Schistosomamansoni infec-
tion, Foxp3 Treg cells are activated and suppress egg-elicited Th2 responses, but little is known of their induction and role dur-
ing the early prepatent larval stage of infection. We quantified Foxp3 Treg cell responses during the first 3 weeks of murine S.
mansoni infection in C57BL/6 mice, a time when larval parasites migrate from the skin and transit the lungs en route to the he-
patic and mesenteric vasculature. In contrast to other helminth infections, S. mansoni did not elicit a Foxp3 Treg cell response
during this early phase of infection. We found that the numbers and proportions of Foxp3 Treg cells remained unchanged in
the lungs, draining lymph nodes, and spleens of infected mice. There was no increase in the activation status of Foxp3 Treg cells
upon infection as assessed by their expression of CD25, Foxp3, and Helios. Furthermore, infection failed to induce Foxp3 Treg
cells to produce the suppressive cytokine interleukin 10 (IL-10). Instead, only CD4 Foxp3 IL-4 Th2 cells showed increased
IL-10 production upon infection. These data indicate that Foxp3 Treg cells do not play a prominent role in regulating immu-
nity to S. mansoni larvae and that the character of the initial immune response invoked by S. mansoni parasites contrasts with
the responses to other parasitic helminth infections that promote rapid Foxp3 Treg cell responses.
Ahallmark of parasitic helminths is their ability to persist foryears within their host despite constant pressure from the
immune system. To achieve this, helminths subvert the host im-
mune system by hijacking the regulatory networks that keep it in
check (1, 2). Foxp3 regulatory T (Treg) cells are a principal com-
ponent of this network and are potent suppressors of immunity
(3). As such, they are a key cell type targeted by helminths in
defense against attack from the host immune system (4). The ex-
pansion and activation of Foxp3 Treg cells occur within the first
week of both filarial (5–7) and intestinal (8–10) nematode infec-
tions. This early induction of Foxp3 Treg cells impairs late-stage
effector immunity, to the detriment of host protection (7, 8, 11).
Thus, nematode infections bias early immune responses toward
regulation to benefit their own survival.
Schistosoma mansoni is a blood-dwelling trematode parasite
that is the etiological agent of the tropical disease hepatic schisto-
somiasis (12). Infective S. mansoni cercariae penetrate the skin of
their host and migrate via the circulation, transiting the lungs to
reside as adults in the mesenteric veins, where they mate and lay
eggs (12). Infections of this type are typically chronic, and the liver
fibrosis, portal hypertension, and intestinal bleeding that charac-
terize the disease arise as a consequence of the host immune re-
sponse to the parasite’s eggs (13). During the patent, egg-produc-
ing phase of disease (week 5 onwards), Foxp3 Treg cells are
activated and suppress Th2 responses, controlling immunopa-
thology in the liver (14–16) and in the colon (17). However, little
is known of their role and induction in the early larval lung transit
phase of disease.
Although the protective immune mechanisms underlying re-
sistance to S. mansoni larvae in primary infections are poorly un-
derstood, during challenge infections, it has been shown that im-
mune responses directed against lung-stage S. mansoni larvae are
required for protection (18, 19). Protective immunity is signifi-
cantly elevated in the absence of the suppressive cytokine interleu-
kin 10 (IL-10) (20, 21), suggesting that immunity to S. mansoni
larvae in the lung is inhibited by immune regulation. IL-6 defi-
ciency leads to enhanced Th2 responses and increased protective
immunity to lung-stage S. mansoni larvae (22), and the absence of
IL-6 can impair Foxp3 Treg cell function during Heligmoso-
moides polygyrus infection, resulting in increased Th2 effector re-
sponses and parasite killing (23). These data suggest a role for
Foxp3 Treg cells in the suppression of protective Th2 responses
to S. mansoni larvae in the lungs, potentially via IL-10.
Wehypothesized that larval S.mansoniparasites rapidly co-opt
Foxp3 Treg cell function at an early stage of infection to benefit
their own survival, inducing the activation and expansion of
Foxp3 Treg cells during the period when the larvae are most
vulnerable to immune attack. However, we found that S. mansoni
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larvae do not induce a Foxp3 Treg cell response during the early
stage of infection in C57BL/6 mice. During the first 3 weeks of
infection, there was no expansion in the proportions or numbers
of Foxp3 Treg cells in the lymph nodes (LN) draining the skin
inoculation site, the lungs, the lung-draining LN, or the spleen.
Furthermore, Foxp3 Treg cells at these sites did not exhibit an
increase in activation status in response to infection, as their ex-
pression levels of CD25, Foxp3, and Helios remained constant.
Infection also failed to stimulate the production of IL-10 by
Foxp3 Treg cells, despite increased IL-10 production by CD4
Foxp3 IL-4Th2 cells. These data suggest that, in contrast to the
responses induced by other helminth infections (5–10, 24, 25), S.
mansoni infection does not induce a Foxp3 Treg cell response in
the initial stages of infection.
MATERIALS AND METHODS
Animals, infections, and parasites. Female C57BL/6 mice were bred in-
house and maintained under specific-pathogen-free conditions at the
University of Edinburgh. Mice were used at 6 to 8 weeks of age, and all
animal work was conducted in accordance with the Animals (Scientific
Procedures) Act 1986. Biomphalaria glabrata snails infected with S. man-
soniparasiteswere obtained fromF. Lewis (Biomedical Research Institute,
Rockville, MD). C57BL/6 mice were infected percutaneously with 70 S.
mansoni cercariae. S. mansoni parasite numbers were quantified by portal
perfusion at weeks 2 and 3 to confirm successful infections. A count of
10.4 5.4 (mean standard deviation) parasiteswas recovered atweek 2,
and a count of 10.6 7.9 was recovered at week 3.
Cell purifications and in vitro stimulation. The lungs, lung-draining
thoracic lymph nodes (tLN), inguinal lymph nodes (iLN) draining the
abdominal skin, and spleens were collected. The tLN, iLN, and spleens
were dissociated to obtain a single-cell suspension in RPMI 1640 (Invit-
rogen) supplemented with 100 U/ml penicillin, 100 g/ml streptomycin,
2 mM L-glutamine, and 5% fetal calf serum (FCS). To isolate lung lym-
phocytes, lung lobes were dissociated in RPMI 1640 with 5% FCS (Invit-
rogen), 100 U/ml penicillin–100 g/ml streptomycin, and 2 mM L-glu-
tamine and then incubated in 250 g/ml collagenase D (Roche) and 10
g/ml DNase (Roche) for 30 min at 37°C before being passed through a
70-m nylon mesh. Erythrocytes in spleen and lung preparations were
lysed using red blood cell lysis buffer (Sigma). For measurement of intra-
cellular cytokines, cells were stimulated for 4 h with 0.5 g/ml phorbol
myristate acetate and 1 g/ml ionomycin, with 10 g/ml brefeldin A
added for the final 2 h (Sigma-Aldrich).
Flow cytometry. The following antibodies were used: Alexa Fluor 700-
conjugated anti-CD4 antibody (RM4-5; BDBioscience), fluorescein isothio-
cyanate-conjugated or allophycocyanin-conjugated anti-Foxp3 antibody
(FJK-16S; eBioscience), phycoerythrin-conjugated anti-Helios antibody
(22F6; Biolegend), phycoerythrin-conjugated anti-CD25 antibody (PC61
5.3; Invitrogen), phycoerythrin-conjugated anti-IL-4 antibody (11B11), Al-
exaFluor647-conjugatedanti-IL-13antibody (ebio13A; eBioscience),Pacific
blue-conjugated anti-T cell receptor  (TCR-) antibody (H57-597; Bioleg-
end), allophycocyanin-conjugated anti-IL-10 antibody (JES5-16E3; eBiosci-
ence), and fluorescein isothiocyanate-conjugated anti-gamma interferon
(IFN-) antibody (XMG1.2; BD Bioscience). Nonspecific binding was
blockedwith 4g of rat IgGper 1 106 cells. Intracellular staining for Foxp3
and Helios was performed using a Foxp3-staining buffer kit (eBioscience).
For intracellular cytokine staining, dead cells were excluded using the Live/
Dead aqua dead cell stain kit (Molecular Probes), and cells were fixed and
permeabilized using the BD Cytofix/Cytoperm kit. Flow cytometry was per-
formed using a FACSCanto 2 or an LSR 2 (BD Biosciences), running FACS-
Diva software (BD Biosciences). Analysis was performed using FlowJo (Tree
Star).
Statistics. Statistical analysis was performed using JMP (SAS) version
8. Parametric analysis of combined data from multiple-repeat experi-
ments or experiments containing more than two groups was performed
using analysis of variance (ANOVA), followed by the least squares means
(LSM) Student’s t test.
RESULTS
Transit of S. mansoni larvae through the lung does not cause
expansion of Foxp3 Treg cells. The rapid recruitment and acti-
vation of Foxp3 Treg cells is a feature of infections with parasitic
nematodes (7–9, 14, 26).However, the role of Foxp3Treg cells in
immunity to early-stage S. mansoni infection is unclear. To ad-
dress whether Foxp3 Treg cell responses are evoked during the
initial stages of S. mansoni infection, as the larvae transit from the
skin through the lungs to the hepatic portal and mesenteric vas-
culature, we infected C57BL/6 mice with 70 S. mansoni cercariae
and measured Foxp3 responses in the iLN (draining the skin site
of inoculation), lungs, tLN (draining the lungs), and spleen at days
7, 14, and 21 postinfection (p.i.). Throughout this period, there
was no difference in the percentages of CD4 T cells expressing
Foxp3 in the lungs in naive and S. mansoni-infected wild-type
mice (Fig. 1A and B). Although there was a trend for an increase in
the absolute numbers of Foxp3 cells in the lungs of infectedmice,
this did not reach statistical significance (Fig. 1C). Similarly, the
percentages and numbers of Foxp3 CD4 T cells remained un-
changed by S. mansoni infection in the tLN, iLN, and spleen (Fig.
1D to I). Therefore, in contrast to the case for other helminth
infections, early-stage S. mansoni infection does not induce the
expansion of Foxp3 Treg cells in the infection site, draining LN,
or spleen.
Foxp3 Treg cells are not activated by migration of S. man-
soni larvae. Although the proportion of Foxp3 Treg cells was
unaltered during the larval stage of S. mansoni infection (Fig. 1), it
is possible that the Treg cells were in a heightened state of activa-
tion. To determine whether Foxp3Treg cells were activated by S.
mansoni larvae, we measured the expression of CD25, Foxp3, and
Helios on Foxp3T cells in the lungs, tLN, iLN, and spleen during
the first 3 weeks of S. mansoni infection (Fig. 2A). While Helios
expressionwas originally reported to distinguish thymic Treg cells
fromperipheral Treg cells (27),more recent evidence suggests that
it is a marker of Treg cell activation (28). In contrast to the egg
phase of infection, when Foxp3 Treg cells actively control pa-
thology (14–17), there was no significant increase in the mean
fluorescence intensity (MFI) of CD25 expression on Foxp3 Treg
cells in the lungs or at any other sitemeasured during early-stage S.
mansoni infection (Fig. 2B). Similarly, there was no increase in
Foxp3MFI iLN, or spleen during the first 3weeks of infection (Fig.
2C). The expression of the transcription factor Helios also re-
mained constant following infection (Fig. 2D). Taken together,
these data suggest that the migration of S. mansoni larvae through
the lungs does not significantly alter the activation state of Foxp3
Treg cells.
Foxp3Treg cells are not amajorT cell source of IL-10 in the
early stage of S. mansoni infection. The suppressive cytokine
IL-10 can inhibit vaccine-mediated immunity to S. mansoni (20)
and prevents resistance to reinfection (21). To test whether
Foxp3Treg cells produce IL-10 in response to themigration of S.
mansoni larvae, we quantified the expression of Foxp3 and IL-10
by flow cytometry of CD4 T cells at days 14 and 21 p.i. (Fig. 3A).
Due to low lung cell numbers, our analysis was restricted to the
tLN and spleen. There was no increase in the percentage of CD4
Foxp3 Treg cells expressing IL-10 upon infection in either the
tLN or spleen (Fig. 3B and C). In contrast to the Foxp3 Treg cell
Redpath et al.
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FIG 1 S. mansoni larval migration does not expand Foxp3 Treg cells. C57BL/6 mice were infected with 70 S. mansoni cercariae, and CD4 Foxp3 Treg cells
were measured in the lungs, tLN, iLN, and spleen at days 7, 14, and 21 of infection. (A) Representative CD4 and Foxp3 staining of lung CD4 TCR- T cells.
(B to I) Percentages and numbers of CD4 TCR- Foxp3 cells within the lungs (B and C), tLN (D and E), iLN (F and G), and spleen (H and I). Panels show
combined data from 3 independent experiments with 4 to 6mice per group. Symbols represent individual mice, and bars showmean values. Open circles denote
results for naive mice, and closed circles denote results for S. mansoni-infected mice.
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population, at day 21 p.i., there was a significant increase in the
percentage of Foxp3 CD4 T cells producing IL-10 in both the
tLN and spleen (Fig. 3D and E). Infection did not result in in-
creased IL-10 production by CD4 cells (data not shown). This
suggests that Foxp3 Treg cells are not a major source of IL-10
during early S. mansoni infection.
IL-4-producing Th2 cells predominate in the early phase of
infection. The importance of the balance of Th1 versus Th2 im-
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FIG 2 S. mansoni larval migration does not increase the activation level of Foxp3 Treg cells. C57BL/6 mice were infected with 70 S. mansoni cercariae, and the
expression of CD25, Foxp3, and Helios was quantified on CD4 TCR- Foxp3 Treg cells in the lungs, iLN, tLN, and spleen on days 7, 14, and 21 p.i. (A)
Representative staining showing Foxp3 versus CD25 and Helios in the lungs at day 14 p.i. (B to D) Bar graphs showingMFI of CD25 (B), Foxp3 (C), and Helios
(D) on CD4 TCR- Foxp3 Treg cells. Panels are representative of three separate experiments with 4 to 6 mice per group. Bars showmean values, and error
bars show standard deviations. Open bars denote results for naive mice, and shaded bars denote results for S. mansoni-infected mice.
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mune responses during early schistosome infection remains con-
troversial. While vaccine studies originally indicated that the ini-
tial immune response to invading S. mansoni larvae is primarily
Th1 (18, 29), more recent evidence has shown that Th2 immune
responses are also induced at this stage of infection (30). To gain a
further understanding of the character of the initial immune re-
sponse directed against S. mansoni larvae, we measured CD4 T
cell IFN- and IL-4 production at days 7, 14, and 21 p.i. in the iLN
and spleen and at days 14 and 21 p.i. in the tLN by intracellular
cytokine staining. Due to limited cell numbers, we were unable to
perform intracellular cytokine staining at day 7 p.i. in the tLN. In
agreement with previous data (31), we observed significantly in-
creased CD4 T cell IFN- production in the spleen at day 21 p.i.
(Fig. 4A). However, IFN- was not detected at earlier time points
(days 7 and 14) in the spleen or at any time p.i. in the tLN and iLN.
In contrast, IL-4-expressing T cells increased significantly by day 7
p.i. in the spleen and iLN and remained elevated through days 14
and 21 (Fig. 4B). Similarly, IL-4-expressing T cells increased sig-
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FIG 3 Foxp3Treg cells do not increase IL-10 production during early-stage S.mansoni infection. C57BL/6mice were infectedwith 70 S.mansoni cercariae, and
IL-10 production by Foxp3 CD4 TCR- T cells and Foxp3 CD4 T cells was measured in the spleen and tLN at days 14 and 21 p.i. (A) Representative
staining for Foxp3 and IL-10 production by splenic CD4 T cells. (B and C) Percentages of Foxp3 and Foxp3 IL-10 cells within the CD4 TCR-
populations at day 14 p.i. in the tLN (B) and spleen (C). (D and E) Percentages of Foxp3 and Foxp3 IL-10 cells within the CD4TCR- populations at day
21 p.i. in the tLN (D) and spleen (E). Panels show combined data from two separate experiments with 4 to 6 mice per group. Bars show mean values, and error
bars show standard deviations. Open bars denote results for naive mice, and shaded bars denote results for S. mansoni-infected mice. **, significant effect of
infection (P	 0.005, ANOVA based on combined data from two independent experiments); ¶, significant pairwise comparison (P	 0.05, LSM Student’s t test).
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nificantly in the tLN at days 14 and 21 p.i. (Fig. 4B). This, along
with the IL-10 data, indicates that the lack of a Foxp3 Treg cell
response is not due to a failure to mount an immune response
toward the larvae and that, while amixed Th1 and Th2 response is
mounted toward S. mansoni larvae, IL-4-producing Th2 cells pre-
dominate during this early period of infection.
CD4 T cell-derived IL-10 is produced by IL-4 Th2 cells in
the early phase of infection.Evidence suggests that during the egg
phase of S. mansoni infection, the dominant cellular sources of
suppressive IL-10 are either Th2 or Tr1 cells (14, 21, 32, 33). To
test the contribution of these cells to the IL-10 produced in the
early phase of infection, we measured the proportions of CD4
Foxp3 IL-10 T cells coexpressing IFN- and IL-4. The largest
population of IL-10 secretors was IL-4 IFN- in both naive and
infected mice (Fig. 5A and B). However, the proportion of these
cells was significantly reduced upon S. mansoni infection, indicat-
ing that S. mansoni infection does not stimulate IL-10 IL-4
IFN- Tr1 cells within the tLN or spleen. Instead, at day 21 p.i.,
there were significantly increased percentages of IL-4 IFN-
cells within the CD4 Foxp3 IL-10 T cell populations in both
the tLN and spleen (Fig. 5C) and no change in the proportions of
IL-4 IFN- cells (Fig. 5D). Similarly, there was an increase in
the total numbers of CD4 Foxp3 IL-10 IL-4 IFN- T cells
but no change in the total numbers of CD4 Foxp3 IL-10
IL-4 IFN- or CD4 Foxp3 IL-10 IL-4 IFN- T cells
(data not shown). These data indicate that IL-4Th2 cells increase
their production of IL-10 in the LN and spleen during early S.
mansoni infection.
DISCUSSION
Schistosomiasis is one of the most important neglected tropical
diseases, with over 200 million people afflicted in many low- and
middle-income countries (34). Chronic infection has been asso-
ciated with increased immunoregulatory mechanisms, including
the expansion of regulatory T cells (35, 36) and the dampening of
allergic and autoimmune responses to bystander antigens (37–
40). Rapid expansion of Foxp3 Treg cells has been clearly shown
to occur in the early phase of several helminth infections, such as
nematode parasites in mouse models, resulting in impaired pro-
tective immunity. Foxp3Treg cells rapidly become activated and
increase in number during the larval stages of Litomosoides sig-
modontis infection, and ablation of CD25 Treg cells before or
during infection enhances parasite killing (7, 25, 41). Similarly,
early expansion of Foxp3 Treg cells that inhibit type 2 immunity
is observed during intestinal nematode infections with H. po-
lygyrus,Trichuris muris, and Strongyloides ratti (8, 9, 11, 24, 42). In
S. ratti and T. muris infections, Foxp3 Treg cells act very early,
and protective immunity can only be restored if they are depleted
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FIG 5 IL-4 Th2 cells are the dominant source of IL-10 during early-stage S. mansoni infection. C57BL/6 mice were infected with 70 S. mansoni cercariae, and
the production of IL-4 and IFN- by IL-10 Foxp3 CD4 T cells was measured in the spleen and tLN at day 21 p.i. (A) Representative staining for IL-4 and
IFN- production by tLN IL-10 Foxp3 CD4 T cells. (B to D) Percentages of IL-4 IFN- cells (B), IL-4 IFN- cells (C), and IL-4 IFN- cells (D)
within the IL-10 Foxp3 CD4 T cell populations in the tLN and spleen at day 21 p.i. Panels show combined data from two separate experiments with 4 to 6
mice per group. Symbols represent results for individual mice, and bars showmean values. Open circles denote results for naive mice, and closed circles denote
results for S. mansoni-infected mice. ***, significant effect of infection (P	 0.0001, ANOVA based on combined data from two independent experiments); ¶,
significant pairwise comparison (P	 0.05, LSM Student’s t test).
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prior to day 4 or day 9 of infection, respectively (8, 11, 24). Hence,
we investigated whether S. mansoni parasites would also induce
Foxp3 Treg cell expansion during the early stages of infection
when the parasites transit the lungs. However, our study demon-
strates that, in contrast to the response to other helminths,
Foxp3 Treg cells do not expand, upregulate activation markers,
or produce IL-10 during the early larval stages of S. mansoni in-
fection in C57BL/6 mice.
Altogether, this suggests that migrating S. mansoni larvae do
not initiate a Foxp3 Treg cell response in C57BL/6mice and that
co-option of Treg cell function is not a survival strategy used by S.
mansoni parasites to avoid host immune attack. In keeping with
this, depletion of CD25 T cells immediately prior to S. mansoni
infection of C57BL/6 mice does not affect the parasite burden
(15). Although overt Foxp3 Treg cell activity was not detected, it
is possible that Foxp3 Treg cells are playing a subtle role in reg-
ulating early immunity to S. mansoni larvae, and functional stud-
ies are required to confirm this. The lack of Foxp3 Treg cell
expansion during the larval stages of infection in C57BL/6 mice
contrasts with the evident Foxp3 Treg cell activity during the
chronic phase of infection, following egg release (week 5 onwards)
(14–17), although it is not known whether Foxp3 Treg cells are
recruited to or activated in the lungs during pulmonary schisto-
somiasis. Similarly, in BALB/c mice, there is little evidence of
Foxp3Treg cell expansion at week 4 p.i., prior to egg release (43).
An interesting future direction for investigation will be to deter-
mine whether only S. mansoni eggs and not S. mansoni parasites
stimulate Foxp3 Treg cells.
Exposure to S. mansoni egg antigens induces Foxp3 expression
in CD4 T cells from NOD mice but not C57BL/6 mice (44).
Similarly, depletion of Foxp3 Treg cells increases resistance to S.
ratti in BALB/c mice but not in C57BL/6 mice (24). Thus, the
importance of Foxp3 Treg cell responses during helminth infec-
tions can differ depending on themouse strain, with Foxp3 Treg
cells potentially playing a lesser role in C57BL/6 mice. However,
C57BL/6 mice are capable of mounting strong Foxp3 Treg cell
responses to helminths, as rapid Foxp3 Treg cell responses are
seen in response to filarial nematodes (7) and Foxp3 Treg cell
depletion promotes resistance to T. muris (11). Thus, while it is
likely that the lack of Foxp3 Treg cell activity in early S. mansoni
infection is a general feature of infection, there remains the possi-
bility that in other, as yet untested strains, Foxp3 Treg cell acti-
vation and expansion may occur.
S. mansoni employs a number of strategies for defense against
host immunity, such that it may not need to utilize Foxp3 Treg
cells for this purpose. For example, S. mansoni parasites have ac-
quired the ability to hide from the host’s immune system, secret-
ing amembranocalyx that surrounds them and shields vulnerable
surface proteins from immune recognition (45). Embedded in the
membranocalyx are blood group antigens and host major histo-
compatibility complex (MHC) molecules that disguise the para-
sites from immune attack (46, 47).
At the cellular level, widespread interactions occur between
schistosomes and host immune populations. Thus, larval secre-
tions generate a population of antigen-presenting cells that prime
CD4 T cells to produce high levels of the suppressive cytokine
IL-10 (48). In addition, IL-10 from a range of different cell types,
including regulatory B cells and innate effector cells, is important
in chronic schistosomiasis (49–52), but to date, no evidence of
their activation in the early larval stage of infection has been ob-
tained.
In contrast, early CD4 T cell IL-10 expression is observed
during vaccination settings, in which radiation-attenuated S.
mansoni larvae stimulate the production of IL-10, which sup-
presses the development of a robust Th1 response in the skin-
draining lymph nodes (53, 54). The induction of Th1 cells in the
skin-draining lymph nodes is required for their recruitment to the
lung (18), where they initiate the formation of inflammatory foci
which block the passage of transiting larvae (19), and in the ab-
sence of IL-10, protective immunity to S. mansoni infection is
enhanced (20). Similarly, IL-10 prevents the development of pro-
tective memory responses to S. mansoni larvae (21). This suggests
that the induction of IL-10 is a key survival strategy used by S.
mansoni larvae for evasion of host immunity.
While IL-10 impairs protective immunity during the early
stages of S.mansoni infection (20), during the egg phase of disease,
IL-10 acts primarily to suppress immunopathology (55). Al-
though Foxp3 Treg cells are a major source of IL-10 at the site of
H. polygyrus infection (10), evidence suggests that the majority of
T cell-derived IL-10 produced during the patent egg phase of S.
mansoni infection comes from Foxp3 Th2 cells (14, 21, 33), al-
though there is some evidence for the induction of Tr1 cells (32).
Similarly, CD4 Foxp3T cells are themain T cell source of IL-10
in other filarial and intestinal helminth infections (56–58). We
observed that the largest population of IL-10-producing CD4 T
cells in both naive and infectedmice was negative for Foxp3, IL-4,
and IFN-. However, during early S. mansoni infection, the pro-
portion of these cells declined and a population of IL-10 Foxp3
CD4 IL-4 IFN- Th2 cells emerged. This suggests that Th2
cells are the main T cell population stimulated to produce IL-10
during both the lung and egg stage of S. mansoni infection. There-
fore, the lack of an early lung-stage Foxp3 Treg cell response
could reflect the fact that non-Treg, Th2 cell-derived IL-10 plays a
suppressive role, and S. mansoni does not need to elicit a Foxp3
Treg cell response to evade immune attack.
In summary, this work has demonstrated that the character
of the initial immune response invoked by S. mansoni parasites
in C57BL/6 mice contrasts with the responses to other parasitic
helminth infections, which promote rapid Foxp3 Treg cell re-
sponses. Thus, S. mansoni larvae do not cause the activation of,
expansion of, or IL-10 production by Foxp3 Treg cells during
the early migratory phase of infection. This suggests that
Foxp3 Treg cells do not play a major role in regulating immu-
nity to schistosome larval stages and that co-option of Treg cell
function is not a survival mechanism employed by this trema-
tode parasite.
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